The Impact of Local Estrogen on the Urogenital Microbiome in Genitourinary Syndrome of Menopause: A Randomized-Controlled Trial

Keyphrases

• Randomized Controlled Trial 100%
• Genitourinary Syndrome of Menopause 100%
• Environmental Estrogens 100%
• Urogenital Microbiome 100%
• Urinary Bladder 75%
• Bladder Microbiome 75%
• Vaginal Ring 75%
• Lactobacillus 50%
• Postmenopausal Women 50%
• Microbiological Analysis 50%
• Relative Abundance 50%
• Menopause Symptoms 50%
• Microbial Community 25%
• Placebo 25%
• Estrogen 25%
• Validated Questionnaire 25%
• Well-defined 25%
• Urine Samples 25%
• Baseline Characteristics 25%
• Intention to Use 25%
• Catheterized 25%
• Index Analysis 25%
• Vaginal pH 25%
• Intention-to-treat Analysis 25%
• Urinary Frequency 25%
• Evaluation Standard 25%
• Bacterial Composition 25%
• Female Sexual Function Index 25%
• Painful Intercourse 25%
• Urinary Urgency 25%
• 16S Ribosomal RNA Sequencing 25%
• Vaginal Maturation Index 25%
• Pelvic Floor Distress Inventory 25%
• Vaginal Estrogen 25%
• Clinical Association 25%
• Symptom Questionnaire 25%
• Vaginal Samples 25%
• Vulvovaginal Disorders 25%
• Vulvovaginal Dryness 25%

Medicine and Dentistry

• Randomized Controlled Trial 100%
• Microbiome 100%
• Estrogen 100%
• Bladder 50%
• Vagina Ring 50%
• Arm 33%
• Postmenopause 33%
• Menopausal Symptom 33%
• Lactobacillus 33%
• Urinary System 16%
• Maturation 16%
• Pelvic Floor 16%
• Intention-to-Treat Analysis 16%
• RNA Gene 16%
• RNA 16S 16%
• Urine Sampling 16%
• Sexual Intercourse 16%
• Urinary Frequency 16%
• Gene Sequence 16%
• Female Sexual Function Index 16%
• Placebo 16%
• Urinary Urgency 16%

Immunology and Microbiology

• Microbiome 100%
• Bladder 50%
• Arm 33%
• Postmenopause 33%
• Lactobacillus 33%
• Vagina pH 33%
• Maturation 16%
• Gene Sequence 16%
• Urine Sampling 16%
• RNA Gene 16%
• Urinary Frequency 16%
• Pelvis 16%
• Sexual Function 16%